Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Safety and Tolerability of Anti-MIF Antibody in Subjects With Lupus Nephritis

NCT01541670 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT01541670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01541670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Safety and Tolerability of Anti-MIF Antibody in Subjects With Lupus Nephritis
Lead sponsor
Baxalta now part of Shire
Phase
Phase 1
Overall status
Terminated
Start date
November 28, 2011
Completion date
December 31, 2012
Enrollment
4 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus